Stoke Therapeutics, Inc. Common Stock
$28.57
Market Cap
$1.80B
Shares Outstanding
64.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jun 19, 2019
Round Lot
100
Locale
US
Day Open
$28.41
Day High
$29.13
Day Low
$28.36
Volume
724.7K
VWAP
$28.84
Prev Close
$27.91
Transactions
--
Acc. Volume
--
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
Stoke Therapeutics, Inc. Common Stock (STOK) closed the 2026-09-17 session at $28.57, up 2.36% versus the previous close (+0.66). The stock opened at $28.41 and traded between $28.36 and $29.13 during that session. Session trading volume was 725K shares. The volume-weighted average price (VWAP) is $28.84.
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
Stoke Therapeutics, Inc. Common Stock has a market capitalization of $1.80 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. STOK is listed on the XNAS exchange. The company employs approximately 170 people. Stoke Therapeutics, Inc. Common Stock is headquartered in BEDFORD, MA. The recorded listing date is 2019-06-19.
On this page you can find market STOK stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.